Peh-Med

About

Q&A

What is Peh-Med's primary business?

Peh-Med develops IntelliDrug, a platform for intraoral drug delivery that offers an alternative to traditional methods like injections and pills. It allows precise dose definition, controlled delivery, and adjustment based on health status.

When was Peh-Med founded?

Peh-Med was founded in January 2007.

What is the current status of Peh-Med?

Peh-Med is currently inactive, a status it has held since November 2016.

How many employees does Peh-Med have?

Peh-Med has an employee count in the 1-10 range.

What is Peh-Med's primary sector classification?

Peh-Med's primary sector is Health Tech & Life Sciences.

Where is Peh-Med headquartered?

Peh-Med is headquartered in Kiryat Ono, Center District, Israel.

What is the current funding stage of Peh-Med?

Peh-Med is currently in the Pre-Funding stage.

What are the key features of Peh-Med's IntelliDrug device?

The IntelliDrug device enables users to accurately define each dose, precisely start and stop drug delivery, and adjust the dose based on variations in health status. Its automatic operation helps overcome issues with patients forgetting medication and can be adjusted for factors like weight, age, and sex.

Sectors & technology

Tags